Generalized Bullous Fixed Drug Eruption due to Clopidogrel Hypersensitivity Successfully Treated Using the Jefferson Procedure.

J Cutan PatholMay 11, 2026 (epub)
Case ReportDermatologyCardiologyOpen access

Jordan Gillespie, Angela J Jiang, Nicole Fett et al.

✦ AI-curated · Sources linked

Case in brief

An 80-year-old male presented with generalized bullous fixed drug eruption (GBFDE) due to hypersensitivity to clopidogrel. The clinical features and histopathological findings confirmed the diagnosis. The patient was treated successfully with the Jefferson desensitization protocol, allowing for the continuation of clopidogrel therapy.

What made this case unusual

This case highlights clopidogrel as a rare cause of GBFDE, which is often confused with more severe conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis.

Diagnostic / clinical pearl

Histopathological evaluation is crucial in differentiating generalized bullous fixed drug eruption from Stevens-Johnson syndrome and toxic epidermal necrolysis.

Why it matters

This case underscores the need for dermatological awareness of clopidogrel hypersensitivity and the potential for successful management using the Jefferson desensitization protocol.

Source

Published in J Cutan Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.